The story so far: Last week, India reached out to Australia to procure monoclonal antibody doses to combat the Nipah virus outbreak in Kerala. According to research published in The Lancet journal of Infectious Diseases, m102.4 is a “potent, fully human” monoclonal antibody that neutralises Hendra and Nipah viruses, both outside and inside of living organisms. According to a research …
The mortality rate of the Nipah virus is much higher than Covid-19 viral disease, said ICMR DG Dr Rajeev Bahl on Friday. According to the Indian Council of Medical Research, the mortality rate of Nipah is around 60% as compared to that of Covid which was nearly 3% in the country. Rajeev Bahl emphasized that all the current cases of …
Director general of the Indian Council of Medical Research Rajeev Bahl on Friday said the mortality rate among those infected with the Nipah virus is much higher compared to that of Covid-19 pandemic. India to procure doses of monoclonal antibody from Australia According to the ICMR DG, India will be procuring 20 more doses of monoclonal antibody from Australia for …
In the face of the ongoing Nipah virus threat, Dr. Rajiv Bahl, the Director-General of the Indian Council of Medical Research, has emphasised a series of precautionary measures aimed at containing the virus's spread. Dr. Bahl notes a stark contrast between Nipah and COVID-19, with the former exhibiting a mortality rate ranging between 40% and 70%, far surpassing the relatively …
The Director General of the Indian Council of Medical Research Rajeev Bahl on Friday warned that the mortality rate in Nipah virus infection cases is very high compared to the Covid-19 infection. The mortality rate in Nipah virus cases is between 40 and 70 per cent, as compared to the mortality in Covid, which was 2-3 per cent, he said. …